A leukemic change as an initial manifestation of the common variant type of ALK-positive anaplastic large cell lymphoma in a patient with lung adenocarcinoma

Internal Medicine

Volumn 47, Issue 23, 2008, Pages 2057-2062

  Matsushita, Hiromichi ^a   Nakamura, Naoya ^a   Asai, Satomi ^a   Yabe, Miharu ^a   Hayama, Naoki ^a   Kondo, Yusuke ^a   Urano, Tetsuya ^a   Miyachi, Hayato ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaplastic large cell lymphoma (ALCL); Common variant type; Lactic acidosis; Leukemic presentation; Lung adenocarcinoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTIBIOTIC AGENT; BICARBONATE; CATECHOLAMINE; CD30 ANTIGEN; CISPLATIN; GEMCITABINE;

AGED; ARTICLE; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CONSCIOUSNESS DISORDER; FATALITY; HUMAN; HYPOGLYCEMIA; HYPOTENSION; IMMUNOHISTOCHEMISTRY; LACTIC ACIDOSIS; LARGE CELL LYMPHOMA; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ADENOCARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; RADIATION PNEUMONIA;

ADENOCARCINOMA; AGED, 80 AND OVER; ANTIGENS, CD30; DIAGNOSIS, DIFFERENTIAL; GENETIC VARIATION; HUMANS; LUNG NEOPLASMS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE;

EID: 61749094470     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1297     Document Type: Article

References (20)

1. Delsol G, Ralfkier E, Stein H, et al. Anaplastic large cell lymphoma. In: Pathology and Genetics of Tumours Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, et al, Eds. IARC Press, Lyon, 2001: 230-235.
2. Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114: 741-760, 2001.
3. Stein H, Foss HD, Dürkop H, et al. CD30 (+) anaplastic large cell lymphoma a review of its histopathologic, genetic, and clinical features. Blood 96: 3681-3695, 2000.
4. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263: 1281-1284, 1994 (Erratum in Science 267: 316-317,1995).
5. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66: 848-858, 1985.
6. Brugières L, Deley MC, Pacquement H, et al. CD30 (+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92: 3591-3598, 1998.
7. Trillet-Lenoir VN, Arpin D, Brune J. Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res 14: 2795-2797, 1994.
8. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347: 649-653, 1996.
9. Pantel K, Izbicki JR, Angstwurm M, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53: 1027-1031, 1993.
10. Osaki T, Oyama T, Gu CD, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 20: 2930-2936, 2002.
11. Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies case report and review of the literature. Cancer 92: 2237-2246, 2001.
12. He YF, Wei W, Sun ZM, et al. Fatal lactic acidosis and hypoglycemia in a patient with relapsed natural killer/T-cell lymphoma. Adv Ther 24: 505-509, 2007.
13. Friedenberg AS, Brandoff DE, Schiffman FJ. Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review. Medicine (Baltimore) 86: 225-232, 2007.
14. Onciu M, Behm FG, Raimondi SC, et al. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature. Am J Clin Pathol 120: 617-625, 2003.
15. Grewal JS, Smith LB, Winegarden JD 3rd, Krauss JC, Tworek JA, Schnitzer B. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature. Ann Hematol 86: 499-508, 2007.
16. Anderson MM, Ross CW, Singleton TP, Sheldon S, Schnitzer B. Ki-1 anaplastic large cel lymphoma with a prominent leukemic phase. Hum Pathol 27: 1093-1095, 1996.
17. Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4 - anaplastic lymphoma kinase gene fusion. Blood 98: 1209-1216, 2001.
18. Tarin F, Miguel-García A, Linares M, et al. Peripheral blood identification of neoplastic cells and the tumoral growth fraction by double immunocytochemical study in a case of anaplastic CD30-positive large cell lymphoma. Leukemia 10: 1560, 1996.
19. Rabasa P, Domingo JM, Quílez D, Monzon F. Ki-1+ large-cell anaplastic lymphoma with a leukemic appearance. Study of a case. Sangre (Barc) 43: 240-243, 1998 (in Spanish).
20. Tamura K, Tashiro H, Kondoh S, et al. Ki-1 (CD30)-positive large cell lymphoma presented with leukemia: a case report. Fukuoka Igaku Zasshi 85: 366-371, 1994.